Literature DB >> 15233914

Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria.

Piera Pasinelli1, Mary Elizabeth Belford, Niall Lennon, Brian J Bacskai, Bradley T Hyman, Davide Trotti, Robert H Brown.   

Abstract

Familial amyotrophic lateral sclerosis (ALS)-linked mutations in the copper-zinc superoxide dismutase (SOD1) gene cause motor neuron death in about 3% of ALS cases. While the wild-type (wt) protein is anti-apoptotic, mutant SOD1 promotes apoptosis. We now demonstrate that both wt and mutant SOD1 bind the anti-apoptotic protein Bcl-2, providing evidence of a direct link between SOD1 and an apoptotic pathway. This interaction is evident in vitro and in vivo in mouse and human spinal cord. We also demonstrate that in mice and humans, Bcl-2 binds to high molecular weight SDS-resistant mutant SOD1 containing aggregates that are present in mitochondria from spinal cord but not liver. These findings provide new insights into the anti-apoptotic function of SOD1 and suggest that entrapment of Bcl-2 by large SOD1 aggregates may deplete motor neurons of this anti-apoptotic protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15233914     DOI: 10.1016/j.neuron.2004.06.021

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  166 in total

1.  A high-throughput screening method for small-molecule inhibitors of the aberrant mutant SOD1 and dynein complex interaction.

Authors:  Xiaohu Tang; Kathleen I Seyb; Mickey Huang; Eli R Schuman; Ping Shi; Haining Zhu; Marcie A Glicksman
Journal:  J Biomol Screen       Date:  2011-12-01

2.  Mutant SOD1 forms ion channel: implications for ALS pathophysiology.

Authors:  Michael J Allen; Jérome J Lacroix; Srinivasan Ramachandran; Ricardo Capone; Jenny L Whitlock; Ghanashyam D Ghadge; Morton F Arnsdorf; Raymond P Roos; Ratnesh Lal
Journal:  Neurobiol Dis       Date:  2011-09-10       Impact factor: 5.996

3.  Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria.

Authors:  Han-Xiang Deng; Yong Shi; Yoshiaki Furukawa; Hong Zhai; Ronggen Fu; Erdong Liu; George H Gorrie; Mohammad S Khan; Wu-Yen Hung; Eileen H Bigio; Thomas Lukas; Mauro C Dal Canto; Thomas V O'Halloran; Teepu Siddique
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

Review 4.  Import, maturation, and function of SOD1 and its copper chaperone CCS in the mitochondrial intermembrane space.

Authors:  Hibiki Kawamata; Giovanni Manfredi
Journal:  Antioxid Redox Signal       Date:  2010-11-01       Impact factor: 8.401

Review 5.  Stem cell-based models and therapies for neurodegenerative diseases.

Authors:  Shilpa Iyer; Khaled Alsayegh; Sheena Abraham; Raj R Rao
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 6.  Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis.

Authors:  Giovanni Manfredi; Hibiki Kawamata
Journal:  Neurobiol Dis       Date:  2015-08-15       Impact factor: 5.996

Review 7.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 8.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

9.  Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice.

Authors:  Chetan Vijayvergiya; M Flint Beal; Jochen Buck; Giovanni Manfredi
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

10.  Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities.

Authors:  Jordi Magrané; Isabel Hervias; Matthew S Henning; Maria Damiano; Hibiki Kawamata; Giovanni Manfredi
Journal:  Hum Mol Genet       Date:  2009-09-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.